Genosco is a clinical-stage biotech pursuing discovery and development of novel small-molecule drugs for patients with unmet medical needs. Our proprietary G-SMART™ platform enables discovery and optimization based on rare sequences in protein kinases that can be targeted to develop a highly selective compound. This innovative approach has enabled us to build a strong portfolio of multiple independent and partnered pipelines. Our most advanced pipeline, Lazertinib, is currently undergoing phase 3 global clinical trial by Janssen and is also available in Korea for patients with EGFRm+ non-small cell lung cancer. Robust research and discovery programs are also underway. With a shared mission to enhance people’s lives through innovative science, we are united in developing world-class precision medicine to help people have healthier and longer lives. Our interdisciplinary team consists of scientists with deep expertise in medicinal chemistry, structural & computational drug discovery design, cell biology, pharmacology, and drug metabolism.
View Top Employees from GenoscoWebsite | http://www.genosco.com |
Revenue | $9 million |
Employees | 25 (20 on RocketReach) |
Founded | 2008 |
Address | 43 Manning Rd, Billerica, Massachusetts 01821, US |
Phone | (617) 494-1460 |
Fax | (617) 714-3443 |
Technologies |
JavaScript,
Nginx,
Slack
+1 more
(view full list)
|
Industry | Biotechnology Research, Business Services General, Biotechnology, Business Services, Science and Engineering |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 32541 Companies |
Looking for a particular Genosco employee's phone or email?
The Genosco annual revenue was $9 million in 2024.
Jae Pyo is the Financial Controller and Director of Genosco.
20 people are employed at Genosco.
Genosco is based in Billerica, Massachusetts.
The NAICS codes for Genosco are [3254, 325, 32, 32541].
The SIC codes for Genosco are [28, 283].